Armira, a holding group focused on direct investments in privately-held medium-sized businesses, completed the acquisition of a 70% stake in G&L Healthcare Advisors, a provider of client-specific consulting services and solutions to support the pharmaceutical, biopharmaceutical, and biotechnology companies. Financial terms were not disclosed. This is a significant transaction in the evolving regulatory and quality consulting space, which will see G&L continue on their impressive growth trajectory towards being the leading transatlantic service provider to healthcare companies globally.